CANNABINOID CLINICAL
LIVE

Serial Number

88791507

Owner

GW Research Limited

Attorney

Michael T. Olsen

First Use Date

Feb 3, 2018

Filing Date

Feb 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CANNABINOID CLINICAL Trademark

Serial Number: 88791507 • Registration: 6623962

CANNABINOID CLINICAL is a trademark filed by GW Research Limited on February 10, 2020. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

Trademark Details

Filing Date

February 10, 2020

Registration Date

January 18, 2022

First Use Anywhere

February 3, 2018

First Use in Commerce

February 3, 2018

Goods & Services

Educational services, namely, conducting classes, seminars, conferences, and workshops in the field of medicine; training services in the field of medicine; provision of information about medical education and training; provision of medical instruction courses; conducting of educational courses and seminars relating to medical matters; providing continuing medical education courses; all of the aforesaid in relation to pharmaceutical and veterinary preparations and substances, herbs for medicinal purposes, medicinal oils and infusions, pure extracts of medicinal plants and herbs, foodstuffs for medicinal purposes, herb teas for medicinal purposes, seeds, flowers and plants

Provision of medical information; provision of medical information in the fields of pharmaceuticals and veterinary pharmaceuticals; provision of medical information in the field of herbs for medicinal purposes, medicinal oils and infusions, pure extracts of medicinal plants and herbs, foodstuffs for medicinal purposes, herb teas for medicinal purposes, seeds, flowers and plants; providing medical information in the field of medical services

Providing medical and scientific research information in the field of pharmaceuticals and veterinary preparations and clinical trials; providing scientific research information and results in the field of medical disorders and their treatment; provision of scientific research information in the fields of pharmaceuticals and veterinary pharmaceuticals

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 20, 2025 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 30, 2024 ASCK
REGISTERED-SUPPLEMENTAL REGISTER
Jan 18, 2022 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 16, 2021 PREV
ASSIGNED TO LIE
Dec 9, 2021 ALIE
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Dec 9, 2021 AAUA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Dec 8, 2021 CNTA
USE AMENDMENT ACCEPTED
Dec 8, 2021 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2021 TEME
AMENDMENT TO USE PROCESSING COMPLETE
Nov 9, 2021 AUPC
USE AMENDMENT FILED
Nov 9, 2021 IUAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 8, 2021 ERSI
TEAS AMENDMENT OF USE RECEIVED
Nov 8, 2021 EAAU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 7, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 7, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
May 7, 2021 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 20, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 20, 2020 GNSL
SUSPENSION LETTER WRITTEN
Oct 20, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 19, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 23, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 23, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 23, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 13, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2020 NWOS
NEW APPLICATION ENTERED
Feb 13, 2020 NWAP